In the BioHarmony Drug Report Database

"Preview" Icon

Megestrol

Megace, Megace Es (megestrol acetate) is a small molecule pharmaceutical. Megestrol acetate was first approved as Megace on 1982-01-01. It is used to treat anorexia, breast neoplasms, cachexia, and endometrial neoplasms in the USA. Megestrol acetate’s patent is valid until 2024-04-22 (FDA).

 

Trade Name

 

Megace, Megace Es
 

Common Name

 

megestrol acetate
 

ChEMBL ID

 

CHEMBL1201139
 

Indication

 

anorexia, breast neoplasms, cachexia, endometrial neoplasms
 

Drug Class

 

Estrogens; progestins

Image (chem structure or protein)

Megestrol structure rendering